222 related articles for article (PubMed ID: 4078724)
1. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
Lauterburg BH; Smith CV; Todd EL; Mitchell JR
J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
Peretti E; Karlaganis G; Lauterburg BH
J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of hydrazine metabolites formed from isoniazid.
Lauterburg BH; Smith CV; Todd EL; Mitchell JR
Clin Pharmacol Ther; 1985 Nov; 38(5):566-71. PubMed ID: 3931954
[TBL] [Abstract][Full Text] [Related]
4. Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid.
Peretti E; Karlaganis G; Lauterburg BH
Eur J Clin Pharmacol; 1987; 33(3):283-6. PubMed ID: 3691615
[TBL] [Abstract][Full Text] [Related]
5. Monoacetylhydrazine as a metabolite of isoniazid in man.
Timbrell JA; Wright JM; Baillie TA
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the metabolism of [14C]acetylhydrazine in rats.
Wright JM; Timbrell JA
Drug Metab Dispos; 1978; 6(5):561-6. PubMed ID: 30606
[TBL] [Abstract][Full Text] [Related]
7. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
Timbrell JA; Wright JM
Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727
[TBL] [Abstract][Full Text] [Related]
8. Determination of isoniazid, acetylisoniazid, acetylhydrazine and diacetylhydrazine in biological fluids by high-performance liquid chromatography.
von Sassen W; Castro-Parra M; Musch E; Eichelbaum M
J Chromatogr; 1985 Feb; 338(1):113-22. PubMed ID: 4019638
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit.
Thomas BH; Whitehouse LW; Zeitz W
Fundam Appl Toxicol; 1984 Aug; 4(4):646-53. PubMed ID: 6479511
[TBL] [Abstract][Full Text] [Related]
10. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
Timbrell JA
Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
[TBL] [Abstract][Full Text] [Related]
12. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
Miscoria G; Leneveu A; Walle C; Roux A
Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
[TBL] [Abstract][Full Text] [Related]
13. Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography.
Timbrell JA; Wright JM; Smith CM
J Chromatogr; 1977 Aug; 138(1):165-72. PubMed ID: 893592
[TBL] [Abstract][Full Text] [Related]
14. Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo.
Timbrell JA; Mitchell JR; Snodgrass WR; Nelson SD
J Pharmacol Exp Ther; 1980 May; 213(2):364-9. PubMed ID: 6767840
[TBL] [Abstract][Full Text] [Related]
15. Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man.
Lauterburg BH; Todd EL; Smith CV; Mitchell JR
Hepatology; 1985; 5(4):607-9. PubMed ID: 4018731
[TBL] [Abstract][Full Text] [Related]
16. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
Dubbels R; Kattner E; Sell-Maurer D; Schloot W
Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites.
Mitchell JR; Thorgeirsson UP; Black M; Timbrell JA; Snodgrass WR; Potter WZ; Jollow HR; Keiser HR
Clin Pharmacol Ther; 1975 Jul; 18(1):70-9. PubMed ID: 1149365
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line.
Sanfeliu C; Wright JM; Kim SU
Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974
[TBL] [Abstract][Full Text] [Related]
19. Effect of rifampin, phenobarbital pretreatment, and acetylator phenotype on acetylisoniazid metabolism in the rabbit.
Thomas BH; Zeitz W; Whitehouse LW
Can J Physiol Pharmacol; 1987 Mar; 65(3):419-23. PubMed ID: 3580961
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
